Pfizer to issue new version of vaccine that is easier to ship and store
CEO Albert Bourla ‘optimistic’ the shots will prove effective against current variants, says they can quickly be adapted to handle new problematic strains.
.........................But Bourla says the higher cost is justified.
(Natürlich nennt Bourla hier
keine Zahlen, läßt aber durchblicken, dass für die Bestellungen 2022/2023
eine Preiserhöhung stattgefunden hat. Es gibt dann eine entsprechende
Mischkalkulation für die reichen und armen Länder.
“Our strategy is to try with a pricing [that is] able to provide equitable access to all,” he said. Equitable means that more vaccine doses are made available to countries that need it more.
“So we have one tier of pricing, which covers all the high-income countries, Europe is included in that, the US is included in that, Japan, Canada, all the high-income countries,” Bourla said.
“I don’t want to go to what is the price for each one country, but at the largest it is the cost of a meal. So I would say for the value that the vaccine brings, we price that very, very reasonably,” he said.
For countries defined as middle-income by the World Bank, “the price is almost half of what we have in the high-income countries,” the CEO said.
“And for the low-income countries, we have decided to give it on a non-profit basis, of course. So I think this is our strategy, this is our policy. So eventually, this vaccine will reach all the people of the world.
www.timesofisrael.com/...ne-that-is-easier-to-ship-and-store/